Post-Market Surveillance under EU MDR and FDA: From Compliance to Strategic Advantage
Many manufacturers still treat Post-Market Surveillance (PMS) as a regulatory checkbox. That approach doesn’t hold anymore. Under the EU MDR, PMS is a structured and mandatory framework for all medical device classes. It requires continuous, proactive data collection and evaluation throughout the product lifecycle. On the FDA side, the terminology may differ, and a formal […]
Post-Market Surveillance under EU MDR and FDA: From Compliance to Strategic Advantage Read More »






